AAAAAA

   
Results: 1-4 |
Results: 4
In vitro and in vivo uroselectivity of B8805-033, an antagonist with high affinity at prostatic alpha(1A)- vs. alpha(1B)- and alpha(1D)-adrenoceptors
Authors: Eltze, M Boer, R Michel, MC Hein, P Testa, R Ulrich, WR Kolassa, N Sanders, KH
Citation: M. Eltze et al., In vitro and in vivo uroselectivity of B8805-033, an antagonist with high affinity at prostatic alpha(1A)- vs. alpha(1B)- and alpha(1D)-adrenoceptors, N-S ARCH PH, 363(6), 2001, pp. 649-662
Novel selective PDE4 inhibitors. 2. Synthesis and structure-activity relationships of 4-aryl-substituted cis-tetra- and cis-hexahydrophthalazinones
Authors: Van der Mey, M Hatzelmann, A Van Klink, GPM Van der Laan, IJ Sterk, GJ Thibaut, U Ulrich, WR Timmerman, H
Citation: M. Van Der Mey et al., Novel selective PDE4 inhibitors. 2. Synthesis and structure-activity relationships of 4-aryl-substituted cis-tetra- and cis-hexahydrophthalazinones, J MED CHEM, 44(16), 2001, pp. 2523-2535
Localization of the 1,4-dihydropyridine drug acceptor of P-glycoprotein toa cytoplasmic domain using a permanently charged derivative N-methyl dexniguldipine
Authors: Ferry, D Boer, R Callaghan, R Ulrich, WR
Citation: D. Ferry et al., Localization of the 1,4-dihydropyridine drug acceptor of P-glycoprotein toa cytoplasmic domain using a permanently charged derivative N-methyl dexniguldipine, INT J CL PH, 38(3), 2000, pp. 130-140
The inhibitory potency and selectivity of arginine substrate site nitric-oxide synthase inhibitors is solely determined by their affinity toward the different isoenzymes
Authors: Boer, R Ulrich, WR Klein, T Mirau, B Haas, S Baur, I
Citation: R. Boer et al., The inhibitory potency and selectivity of arginine substrate site nitric-oxide synthase inhibitors is solely determined by their affinity toward the different isoenzymes, MOLEC PHARM, 58(5), 2000, pp. 1026-1034
Risultati: 1-4 |